Literature DB >> 8146227

Effects of ventral striatal 6-OHDA lesions or amphetamine sensitization on ethanol consumption in the rat.

C Fahlke1, S Hansen, J A Engel, E Hård.   

Abstract

Female rats with continuous access to water and 6% ethanol were given bilateral ventral striatal 6-OHDA infusions, which induced pronounced striatal depletions of dopamine. The postoperative ethanol consumption of these rats was not significantly affected in comparison to vehicle-infused controls. In a second experiment, female rats received escalating doses of d-amphetamine over a 5-week period (from 1 to 9 mg/kg/injection). Control females were given saline injections. Following a 3-month drug-free interval, the females were given access to ethanol, the concentration of which was gradually increased from 2% to 12% with weekly intervals. Amphetamine-sensitized rats consumed significantly more alcohol than the saline-treated controls. Taken together, these results suggest that striatal dopaminergic mechanisms, while not necessary for basal ethanol drinking, can facilitate alcohol drinking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146227     DOI: 10.1016/0091-3057(94)90020-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

Review 1.  Modeling the diagnostic criteria for alcohol dependence with genetic animal models.

Authors:  John C Crabbe; Kenneth S Kendler; Robert J Hitzemann
Journal:  Curr Top Behav Neurosci       Date:  2013

2.  Drinking to distraction: does alcohol increase attentional bias in adults with ADHD?

Authors:  Walter Roberts; Mark T Fillmore; Richard Milich
Journal:  Exp Clin Psychopharmacol       Date:  2011-11-28       Impact factor: 3.157

Review 3.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

4.  Reduced ethanol consumption by alcohol-preferring (P) rats following pharmacological silencing and deep brain stimulation of the nucleus accumbens shell.

Authors:  Jessica A Wilden; Kurt Y Qing; Sheketha R Hauser; William J McBride; Pedro P Irazoqui; Zachary A Rodd
Journal:  J Neurosurg       Date:  2014-01-24       Impact factor: 5.115

5.  Ethanol is self-administered into the nucleus accumbens shell, but not the core: evidence of genetic sensitivity.

Authors:  Eric A Engleman; Zheng-Ming Ding; Scott M Oster; Jamie E Toalston; Richard L Bell; James M Murphy; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2009-09-17       Impact factor: 3.455

6.  A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration.

Authors:  Peter W Marinelli; Rémi Quirion; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

7.  Methamphetamine self-administration reduces alcohol consumption and preference in alcohol-preferring P rats.

Authors:  Madeline C Winkler; Emilee M Greager; Jacob Stafford; Ryan K Bachtell
Journal:  Addict Biol       Date:  2016-11-16       Impact factor: 4.280

8.  Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects.

Authors:  Helga Höifödt Lidö; Susanne Jonsson; Petri Hyytiä; Mia Ericson; Bo Söderpalm
Journal:  J Neural Transm (Vienna)       Date:  2017-02-04       Impact factor: 3.575

9.  Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats.

Authors:  Paul Ruiz; Aldo Calliari; Patricia Genovese; Cecilia Scorza; Ricardo Marcos Pautassi
Journal:  Brain Behav       Date:  2018-02-19       Impact factor: 2.708

10.  Deletion of the gabra2 gene results in hypersensitivity to the acute effects of ethanol but does not alter ethanol self administration.

Authors:  Claire I Dixon; Sophie E Walker; Sarah L King; David N Stephens
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.